/
IMCC
$0.15+$0.01 (+6.40%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.3M
9M shares
52-week range
$0.12 – $3.75
1% from low
Exchange
NASDAQ
CS
Borrow rate
14.89%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-318.45
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2M | $9.1M | $15.9M | $34.1M | $54.3M | $48.8M | $54.0M | $54.7M |
| Cost of revenue | $999.0K | $5.1M | $5.4M | $27.7M | $45.2M | $39.0M | $45.6M | $45.0M |
| Gross profit | $4.2M | $3.9M | $10.5M | $6.3M | $9.2M | $9.8M | $8.5M | $9.7M |
| Gross margin | 80.8% | 43.3% | 65.9% | 18.6% | 16.9% | 20.2% | 15.6% | 17.7% |
| R&D | $83.0K | $233.0K | $136.0K | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.1M | −$10.3M | −$8.2M | −$23.0M | −$30.8M | −$12.8M | −$10.2M | −$11.6M |
| EBITDA | $3.3M | −$6.0M | −$7.0M | $6.2M | −$16.8M | −$2.8M | −$6.1M | −$6.9M |
| Net income | $1.7M | −$7.3M | −$28.7M | −$17.8M | −$188.9M | −$9.5M | −$10.6M | −$11.3M |
| Net margin | 32.4% | -80.4% | -180.6% | -52.2% | -347.6% | -19.5% | -19.6% | -20.7% |
| EPS (diluted) | 0.60 | -13.80 | -7.45 | -3.00 | -161.88 | -4.45 | -4.51 | -2.67 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $63M | $-0.32 | $-0.32–$-0.32 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
IM Cannabis Corp. Common Shares
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
www.imcannabis.com- Employees
- 44
- IPO / List date
- Feb 13, 1997
Held by traders on TradeandTell
No one on the platform currently holds IMCC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 11,425 | $21.9K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-07-12 | 1-for-6reverse |
| 2022-11-17 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded IMCC yet.
